NEW YORK, August 25, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Phillips 66 (NYSE: PSX), Praxair, Inc. (NYSE: PX), Rockwood Holdings, Inc. (NYSE: ROC), Pioneer Natural Resources (NYSE: PXD) and Marathon Oil Corporation (NYSE: MRO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5935-100free.

-- Phillips 66 Research Reports On August 20, 2014, Phillips 66 (Phillips 66) announced its Chairman and CEO Greg Garland will present at the upcoming 2014 Barclays CEO Energy-Power Conference in New York on September 3, 2014 at 9:45 a.m. EDT. The Company stated that during the conference, Greg will discuss its strategy, including performance in executing its Midstream growth plan. The webcast of the presentation and replay of the same will be available on the Company's website under in the Investors section. The full research reports on Phillips 66 are available to download free of charge at:

http://www.analystsreview.com/Aug-25-2014/PSX/report.pdf

-- Praxair, Inc. Research Reports On August 20, 2014, Praxair, Inc.'s (Praxair) stock ended the day 0.12% lower at $130.43, underperforming the Dow Jones Industrial Average (DJI) that gained 0.35% over the same trading session. Shares in Praxair opened the session at $130.56 and oscillated in the range of $129.43 - $130.56. The stock is trading near is 52-week high of $135.24. Over the past six months, the stock has returned 1.84%. The shares of the Company are trading above their 50-day and 200-day moving averages of $130.29 and $130.06. The full research reports on Praxair are available to download free of charge at:

http://www.analystsreview.com/Aug-25-2014/PX/report.pdf

-- Rockwood Holdings, Inc. Research Reports On August 6, 2014, Rockwood Holdings, Inc. (Rockwood) reported Q2 2014 net sales of $362.3 million, up 4.1% YoY. During the quarter, the Company's Lithium sales declined 7.2% YoY to $116.7 million due to lower volumes from organometallic products, driven mostly by butyllithium, and a 26% YoY decline in potash sales, mainly volumes. However, surface treatment revenues improved 10.8% YoY to $242.3 million primarily due to increased volumes in most markets, particularly driven by higher automotive OEM and automotive components, coil and cold forming, general industry and aerospace applications, the impact of the acquisition of the remaining 50% interest in a previously unconsolidated joint venture in India in 2013; and higher selling prices. The Company's Q2 2014 net income attributable to Rockwood stockholders came in at $46.7 million or $0.64 per diluted share, compared to $31.1 million or $0.39 per diluted share in Q2 2013. On average, seven analysts polled by Thomson Reuters, expected the Company to report Q2 2014 EPS of $0.49 on revenues of $370.03 million. The Company reported H1 2014 net sales of $716.8 million, up 4.6% YoY, while net income attributable to Rockwood stockholders stood at $25.9 million, down 47.0% YoY. The full research reports on Rockwood are available to download free of charge at:

http://www.analystsreview.com/Aug-25-2014/ROC/report.pdf

-- Pioneer Natural Resources Research Reports On August 20, 2014, Pioneer Natural Resources announced that its Board of Directors has declared a cash dividend of $0.04 per share on the Company's outstanding common stock, payable on October 10, 2014 to stockholders of record at the close of business on September 30, 2014. The full research reports on Pioneer are available to download free of charge at:

http://www.analystsreview.com/Aug-25-2014/PXD/report.pdf

-- Marathon Oil Corporation Research Reports On August 4, 2014, Marathon Oil Corporation (Marathon) reported Q2 2014 financial results with total revenues and other income of $2.9 billion, down 1.6% YoY. During the quarter, the Company's net sales volumes declined 8.3% YoY to 464 mboed (million barrels oil equivalent per day). Net income came in at $540 million or $0.80 per diluted share, compared to net income of $426 million or $0.60 per diluted share in Q2 2013. According to 23 analysts polled by Thomson Reuters, the Company was expected to report Q2 2014 EPS of $0.75 on revenues of $3.40 billion. Marathon's H1 2014 total revenue and other income declined 5.2% YoY to $5.8 billion, while net income stood at $1,689 million versus $809 million in H1 2013. The full research reports on Marathon are available to download free of charge at:

http://www.analystsreview.com/Aug-25-2014/MRO/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review